Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jafar Amani

Showing results (41-50 of 167) with videos related to

Pageof 17
Sort By:
European Journal of Pharmacology|January 14, 2020
A new scfv-based recombinant immunotoxin against EPHA2-overexpressing breast cancer cells; High in vitro anti-cancer potencyEhsan Rezaie, Jafar Amani, Ali Bidmeshki Pour, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 21, 2017
Immunotoxin: A new tool for cancer therapyHossein Allahyari, Sahar Heidari, Mehdi Ghamgosha, et al.
Theoretical Biology & Medical Modelling|December 10, 2009
In silico analysis of chimeric espA, eae and tir fragments of Escherichia coli O157:H7 for oral immunogenic applicationsJafar Amani, S Latif Mousavi, Sima Rafati, et al.
Iranian Journal of Pharmaceutical Research : IJPR|December 20, 2023
Designing and Expression of Recombinant Chimeric Spike Protein from SARS-CoV-2 in <i>Escherichia coli</i> and Its Immunogenicity AssessmentSahar Karimi, Shahram Nazarian, Fattah Sotoodehnejadnematalahi, et al.
Heliyon|June 15, 2019
In vivo and in vitro biocompatibility study of novel microemulsion hybridized with bovine serum albumin as nanocarrier for drug deliveryMahmoud Gharbavi, Hamidreza Kheiri Manjili, Jafar Amani, et al.
Iranian Journal of Microbiology|December 9, 2016
Immunoreactivity evaluation of a new recombinant chimeric protein against <i>Brucella</i> in the murine modelAbbas Abdollahi, Shahla Mansouri, Jafar Amani, et al.
Journal of Cellular Physiology|April 27, 2019
The role of inflammation and its related microRNAs in breast cancer: A narrative reviewAlireza Bahiraee, Reyhane Ebrahimi, Raheleh Halabian, et al.
Molecular Biology Research Communications|February 27, 2019
Designing and analyzing the structure of Tat-BoNT/A(1-448) fusion protein: An <i>in silico</i> approachJafar Amani, Parvaneh Saffarian, Shahin Najar-Peerayeh, et al.
Journal of Cellular Biochemistry|November 17, 2017
Design, expression and evaluation of novel chimeric protein constructed from colorectal tumor-associated antigenZiba Veisi Malekshahi, Jafar Amani, Babak Negahdari, et al.
World Journal of Microbiology & Biotechnology|December 11, 2013
Investigation of the antibacterial activity of a short cationic peptide against multidrug-resistant Klebsiella pneumoniae and Salmonella typhimurium strains and its cytotoxicity on eukaryotic cellsMehrdad Moosazadeh Moghaddam, Kamal Azizi Barjini, Mahdi Fasihi Ramandi, et al.
Pageof 17

Showing results (41-50 of 167) with videos related to

Sort By:
Pageof 17
European Journal of Pharmacology|January 14, 2020
A new scfv-based recombinant immunotoxin against EPHA2-overexpressing breast cancer cells; High in vitro anti-cancer potencyEhsan Rezaie, Jafar Amani, Ali Bidmeshki Pour, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 21, 2017
Immunotoxin: A new tool for cancer therapyHossein Allahyari, Sahar Heidari, Mehdi Ghamgosha, et al.
Theoretical Biology & Medical Modelling|December 10, 2009
In silico analysis of chimeric espA, eae and tir fragments of Escherichia coli O157:H7 for oral immunogenic applicationsJafar Amani, S Latif Mousavi, Sima Rafati, et al.
Iranian Journal of Pharmaceutical Research : IJPR|December 20, 2023
Designing and Expression of Recombinant Chimeric Spike Protein from SARS-CoV-2 in <i>Escherichia coli</i> and Its Immunogenicity AssessmentSahar Karimi, Shahram Nazarian, Fattah Sotoodehnejadnematalahi, et al.
Heliyon|June 15, 2019
In vivo and in vitro biocompatibility study of novel microemulsion hybridized with bovine serum albumin as nanocarrier for drug deliveryMahmoud Gharbavi, Hamidreza Kheiri Manjili, Jafar Amani, et al.
Iranian Journal of Microbiology|December 9, 2016
Immunoreactivity evaluation of a new recombinant chimeric protein against <i>Brucella</i> in the murine modelAbbas Abdollahi, Shahla Mansouri, Jafar Amani, et al.
Journal of Cellular Physiology|April 27, 2019
The role of inflammation and its related microRNAs in breast cancer: A narrative reviewAlireza Bahiraee, Reyhane Ebrahimi, Raheleh Halabian, et al.
Molecular Biology Research Communications|February 27, 2019
Designing and analyzing the structure of Tat-BoNT/A(1-448) fusion protein: An <i>in silico</i> approachJafar Amani, Parvaneh Saffarian, Shahin Najar-Peerayeh, et al.
Journal of Cellular Biochemistry|November 17, 2017
Design, expression and evaluation of novel chimeric protein constructed from colorectal tumor-associated antigenZiba Veisi Malekshahi, Jafar Amani, Babak Negahdari, et al.
World Journal of Microbiology & Biotechnology|December 11, 2013
Investigation of the antibacterial activity of a short cationic peptide against multidrug-resistant Klebsiella pneumoniae and Salmonella typhimurium strains and its cytotoxicity on eukaryotic cellsMehrdad Moosazadeh Moghaddam, Kamal Azizi Barjini, Mahdi Fasihi Ramandi, et al.
Pageof 17